Why Add Librium?

https://aihp.org/wp-content/uploads/2022/01/msdac-043.1a-librium.jpg
https://aihp.org/wp-content/uploads/2022/01/msdac-043.2a-librium.jpg

Title

Why Add Librium?

Description

Advertisement for Librium (chlordiazepoxide HCI), a medication manufactured by Roche Laboratories to reduce anxiety. The ad appeared in the journal Medical Economics on January 6, 1975. The ad reports that Librium relieves excessive anxiety in patients with heart disease and serves as an adjunct to primary cardiovascular medications.

Creator

Publisher

Date

Rights

The advertisements in the AIHP Mickey Smith Drug Advertising Collection were published after 1923 and are not in the public domain. Under Fair Use, users may view or reproduce (print or download) materials from the collection for research, teaching, private study, or general interest. Users must provide proper attribution to the AIHP Mickey Smith Drug Advertising Collection in all copies. For any other uses, including reprinting or reproduction, users must contact the current rights holder for permission. For more information about the collection, please contact the American Institute of the History of Pharmacy: aihp@aihp.org.
http://rightsstatements.org/vocab/InC/1.0/

Format

Language

eng

Identifier

msdac-043-librium

Extent

2 pages

Temporal Coverage

Original Format

Citation

Roche, “Why Add Librium?,” American Institute of the History of Pharmacy Digital Collection, accessed April 18, 2024, https://aihp.omeka.net/items/show/672.